325 related articles for article (PubMed ID: 28770269)
1. The PD-1/PD-L1 Inhibitory Pathway is Altered in Primary Glomerulonephritides.
Grywalska E; Smarz-Widelska I; Krasowska-Zajac E; Korona-Glowniak I; Zaluska-Patel K; Mielnik M; Podgajna M; Malm A; Rolinski J; Zaluska W
Arch Immunol Ther Exp (Warsz); 2018 Apr; 66(2):133-143. PubMed ID: 28770269
[TBL] [Abstract][Full Text] [Related]
2. PD-1 and PD-L1 Expression on Circulating Lymphocytes as a Marker of Epstein-Barr Virus Reactivation-Associated Proliferative Glomerulonephritis.
Grywalska E; Smarz-Widelska I; Korona-Głowniak I; Mertowski S; Gosik K; Hymos A; Ludian J; Niedźwiedzka-Rystwej P; Roliński J; Załuska W
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33121190
[TBL] [Abstract][Full Text] [Related]
3. CTLA-4 Expression Inversely Correlates with Kidney Function and Serum Immunoglobulin Concentration in Patients with Primary Glomerulonephritides.
Grywalska E; Smarz-Widelska I; Mertowski S; Gosik K; Mielnik M; Podgajna M; Abramiuk M; Drop B; Roliński J; Załuska W
Arch Immunol Ther Exp (Warsz); 2019 Oct; 67(5):335-349. PubMed ID: 31177287
[TBL] [Abstract][Full Text] [Related]
4. Frequencies of PD-1- and PD-L1- positive T CD3
Nowicka D; Grywalska E; Surdacka A; Grafka A; Roliński J
Microb Pathog; 2019 Jan; 126():85-91. PubMed ID: 30342909
[TBL] [Abstract][Full Text] [Related]
5. PD-L1
Zacca ER; Onofrio LI; Acosta CDV; Ferrero PV; Alonso SM; Ramello MC; Mussano E; Onetti L; Cadile II; Stancich MI; Taboada Bonfanti MC; Montes CL; Acosta Rodríguez EV; Gruppi A
Front Immunol; 2018; 9():2241. PubMed ID: 30327652
[No Abstract] [Full Text] [Related]
6. The Increase of Circulating PD-1- and PD-L1-Expressing Lymphocytes in Endometriosis: Correlation with Clinical and Laboratory Parameters.
Walankiewicz M; Grywalska E; Polak G; Korona-Glowniak I; Witt E; Surdacka A; Kotarski J; Rolinski J
Mediators Inflamm; 2018; 2018():7041342. PubMed ID: 30595667
[TBL] [Abstract][Full Text] [Related]
7. The blockade of PD-1/PD-L1 pathway promotes the apoptosis of CD19
Wang Z; Tan F
Scand J Immunol; 2020 Feb; 91(2):e12836. PubMed ID: 31598989
[TBL] [Abstract][Full Text] [Related]
8. PD-1/PD-L Pathway Potentially Involved in ITP Immunopathogenesis.
Nie M; Liu Y; Li XX; Min YN; Yang DD; Li Q; Feng Q; Hou Y; Li GS; Sun JZ; Hou M; Shi Y
Thromb Haemost; 2019 May; 119(5):758-765. PubMed ID: 30808044
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo effect of PD-1/PD-L1 blockade on microglia/macrophage activation and T cell subset balance in cryptococcal meningitis.
Che YM; Zhang Y; Li M; Li XP; Zhang LL
J Cell Biochem; 2018 Apr; 119(4):3044-3057. PubMed ID: 29058791
[TBL] [Abstract][Full Text] [Related]
10. The PD-1/PD-L1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemia.
Brusa D; Serra S; Coscia M; Rossi D; D'Arena G; Laurenti L; Jaksic O; Fedele G; Inghirami G; Gaidano G; Malavasi F; Deaglio S
Haematologica; 2013 Jun; 98(6):953-63. PubMed ID: 23300177
[TBL] [Abstract][Full Text] [Related]
11. The importance of the PD-1/PD-L1 pathway at the maternal-fetal interface.
Meggyes M; Miko E; Szigeti B; Farkas N; Szereday L
BMC Pregnancy Childbirth; 2019 Feb; 19(1):74. PubMed ID: 30782114
[TBL] [Abstract][Full Text] [Related]
12. Reactive glia promote development of CD103
Prasad S; Hu S; Sheng WS; Chauhan P; Lokensgard JR
Immun Inflamm Dis; 2018 Jun; 6(2):332-344. PubMed ID: 29602245
[TBL] [Abstract][Full Text] [Related]
13. Human brain endothelial cells endeavor to immunoregulate CD8 T cells via PD-1 ligand expression in multiple sclerosis.
Pittet CL; Newcombe J; Prat A; Arbour N
J Neuroinflammation; 2011 Nov; 8():155. PubMed ID: 22067141
[TBL] [Abstract][Full Text] [Related]
14. PD-1-expressing B cells suppress CD4
Wang X; Wang G; Wang Z; Liu B; Han N; Li J; Lu C; Liu X; Zhang Q; Yang Q; Wang G
Mol Immunol; 2019 May; 109():20-26. PubMed ID: 30851633
[TBL] [Abstract][Full Text] [Related]
15. An optimized protocol for the in vitro generation and functional analysis of human PD1/PD-L1 signal.
Khedri M; Abnous K; Rafatpanah H; Ramezani M
J Recept Signal Transduct Res; 2018 Feb; 38(1):31-36. PubMed ID: 29252078
[TBL] [Abstract][Full Text] [Related]
16. TLR2 Expression on Select Lymphocyte Subsets as a New Marker in Glomerulonephritis.
Mertowski S; Grywalska E; Gosik K; Smarz-Widelska I; Hymos A; Dworacki G; Niedźwiedzka-Rystwej P; Drop B; Roliński J; Załuska W
J Clin Med; 2020 Feb; 9(2):. PubMed ID: 32079183
[TBL] [Abstract][Full Text] [Related]
17. Unbalanced expression of membrane-bound and soluble inducible costimulator and programmed cell death 1 in patients with myasthenia gravis.
Yan X; Gu Y; Wang C; Sun S; Wang X; Tian J; Wang M; Ji X; Duan X; Gao H; Fang Q; Dong W; Zhang X; Xue Q
Clin Immunol; 2019 Oct; 207():68-78. PubMed ID: 31374257
[TBL] [Abstract][Full Text] [Related]
18. Programmed death 1 and its ligands do not limit experimental foreign antigen-induced immune complex glomerulonephritis.
Ooi JD; Li M; Kourkoutzelos K; Yagita H; Azuma M; Holdsworth SR; Kitching AR
Nephrology (Carlton); 2015 Dec; 20(12):892-8. PubMed ID: 26043977
[TBL] [Abstract][Full Text] [Related]
19. PD-1 and PD-L1 Expression in Peripheral CD4/CD8+ T Cells Is Restored in the Partial Remission Phase in Type 1 Diabetes.
Li X; Zhong T; Tang R; Wu C; Xie Y; Liu F; Zhou Z
J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32236416
[TBL] [Abstract][Full Text] [Related]
20. Infiltration of CD8 T Cells and Expression of PD-1 and PD-L1 in Synovial Sarcoma.
Nowicki TS; Akiyama R; Huang RR; Shintaku IP; Wang X; Tumeh PC; Singh A; Chmielowski B; Denny C; Federman N; Ribas A
Cancer Immunol Res; 2017 Feb; 5(2):118-126. PubMed ID: 28039162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
